# FDA Inspection 1271320 - Cipla Ltd. - May 30, 2025

Source: https://www.keypedia.com/records/fda_inspections/cipla-ltd/0b1d5c3a-cab6-4504-b566-6362219eb0e0
Source feed: FDA_Inspections

> FDA Inspection 1271320 for Cipla Ltd. on May 30, 2025. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1271320
- Company Name: Cipla Ltd.
- Inspection Date: 2025-05-30
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1271320 - 2025-05-30](https://www.keypedia.com/records/fda_inspections/cipla-ltd/07e0b1bd-cab9-4422-8834-b1e0ebb55d3e)
- [FDA Inspection 1117627 - 2020-01-24](https://www.keypedia.com/records/fda_inspections/cipla-ltd/918145f8-0e2e-4fbf-8733-3d6639a9d001)
- [FDA Inspection 921236 - 2015-03-12](https://www.keypedia.com/records/fda_inspections/cipla-ltd/d528b206-bdf2-4811-88b5-49dda94f10d3)
- [FDA Inspection 768491 - 2011-11-17](https://www.keypedia.com/records/fda_inspections/cipla-ltd/6f02ef12-1475-47c2-a395-592976ffb865)

Company: https://www.keypedia.com/companies/cipla-ltd/d90a952b-3052-4e33-9969-5db3f2bbae82

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c